| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1368-7646(98)80209-4 |
| P698 | PubMed publication ID | 17092791 |
| P50 | author | Frank C. Odds | Q88843128 |
| P2860 | cites work | Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients | Q33483319 |
| Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group | Q35110598 | ||
| Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans | Q36526361 | ||
| Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome | Q36528018 | ||
| Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te | Q36855581 | ||
| Analysis of 1,186 Episodes of Gram-Negative Bacteremia in Non-University Hospitals: The Effects of Antimicrobial Therapy | Q38522396 | ||
| Pseudomonas bacteremia. Review of 108 cases | Q40755444 | ||
| Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients | Q41138015 | ||
| Plasma and tissue concentrations of fluconazole and their correlation to breakpoints | Q41566153 | ||
| Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
| Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients. | Q54154042 | ||
| The in vitro synergistic inhibitory effect of human amniotic fluid and gentamicin on growth of Escherichia coli. | Q54588950 | ||
| Predictive value of susceptibility tests for the outcome of antibacterial therapy | Q68739224 | ||
| Worldwide clinical experience with cefoperazone | Q70556112 | ||
| Effect on Pseudomonas aeruginosa alginate expression of direct plating and culture of fresh cystic fibrosis sputum on to pseudomonas isolation agar containing subinhibitory concentrations of roxithromycin and rifampicin | Q70825673 | ||
| In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance | Q70946866 | ||
| Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics | Q71071262 | ||
| Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility | Q71746293 | ||
| Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology | Q71972430 | ||
| DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS | Q72252090 | ||
| Postantibiotic effects of subinhibitory concentrations of some antibiotics and their influence on Pseudomonas aeruginosa enzymic activity | Q73197519 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 11-15 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Drug Resistance Updates | Q3040081 |
| P1476 | title | Should resistance to azole antifungals in vitro be interpreted as predicting clinical non-response? | |
| P478 | volume | 1 |
| Q33978021 | Accumulation of 3-ketosteroids induced by itraconazole in azole-resistant clinical Candida albicans isolates |
| Q36958193 | Binding Sites in the EFG1 Promoter for Transcription Factors in a Proposed Regulatory Network: A Functional Analysis in the White and Opaque Phases of Candida albicans |
| Q37124804 | Candida albicans forms a specialized "sexual" as well as "pathogenic" biofilm |
| Q37775500 | Conazoles. |
| Q47646968 | Fluconazole Resistance among Oral Candida Isolates from People Living with HIV/AIDS in a Nigerian Tertiary Hospital |
| Q50478769 | In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast One. |
| Q36162343 | Sertaconazole: updated review of a topical antifungal agent. |
Search more.